Cutaneous port-site recurrence secondary to tumour seeding following implantation of an intraperitoneal chemotherapy access port for gastric cancer

Pleura Peritoneum. 2020 May 15;5(2):20200102. doi: 10.1515/pp-2020-0102. eCollection 2020 Jun 1.

Abstract

Intraperitoneal chemotherapy has shown promising results for the treatment of peritoneal carcinomatosis in gastric cancer. However, the implantation of an intraperitoneal chemotherapy port may be associated with catheter-related complications. The authors describe a case of cutaneous port-site recurrence secondary to tumour seeding from an intraperitoneal chemotherapy access port.

Keywords: gastric cancer; intraperitoneal chemotherapy; metastases; neoplasm seeding.